Adding Liver-Directed Therapy to Immunotherapy Doubles Survival in Advanced Liver Cancer
A two-center retrospective study found that adding TACE or HAIC to targeted-immunotherapy nearly doubled median overall survival in advanced hepatocellular ...
A two-center retrospective study found that adding TACE or HAIC to targeted-immunotherapy nearly doubled median overall survival in advanced hepatocellular ...
New research shows that inhibiting the FGFR signaling pathway reduces T cell exhaustion and repolarizes macrophages, significantly enhancing PD-1 blockade ...
A new quantitative systems pharmacology model spanning all three classes of BRAF-mutant lung cancer predicts that MEK-ERK inhibitor combinations can ...
A network meta-analysis of eight randomized trials finds that immune checkpoint inhibitors combined with anti-VEGF therapy outperform other immunotherapy combinations ...
A new review in Cancer Cell International maps how the deubiquitinase USP7 acts as both tumor promoter and suppressor depending ...
New research reveals that the mitochondrial ubiquitin ligase MARCHF5 helps KSHV-transformed lymphoma cells survive by degrading NOXA, the natural antagonist ...
Researchers developed HALO, a machine-learning framework that predicts antibacterial drug synergy from multi-level bioactivity features while exposing how data leakage ...
University of Missouri scientist Ron Mittler is urging biologists to study organisms under multiple simultaneous stressors, arguing that combined stresses ...
A Carrimycin and Azvudine combination showed additive antiviral effects, superior lung protection, and immune benefits in SARS-CoV-2-infected rhesus macaques.
A new review of 28 studies reveals that tigecycline holds strong promise against rapidly growing nontuberculous mycobacteria like M. abscessus, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine